Bombesin
|
WikiDoc Resources for Bombesin |
|
Articles |
|---|
|
Most recent articles on Bombesin |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Bombesin at Clinical Trials.gov Clinical Trials on Bombesin at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Bombesin
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Directions to Hospitals Treating Bombesin Risk calculators and risk factors for Bombesin
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Bombesin |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Bombesin is a 14 amino acid peptide originally isolated from the skin of a frog. It has two known homologues in mammals called neuromedin B and gastrin releasing peptide. It works on the gastrointestinal tract neuroendocrine hormone and it stimulates gastrin release from G cells. It activates three different G-protein coupled receptors known as BBR1 2 & 3. It also activates these receptors in the brain. Together with cholecystokinin it is the second major source of negative feedback signals that stop eating behaviour.
Bombesin is also a tumor marker for gastric cancer and neuroblastoma.
See also